A Study of Tadalafil in Benign Prostatic Hyperplasia

Clinical trial NCT01183650 · COMPLETED

Trial details

NCT number: NCT01183650
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2010-07-01
Primary completion: 2011-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.